Modified CV Regimen in Optic Pathway Glioma

NCT05278715 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

75

Enrollment

OTHER

Sponsor class

Conditions

Optic Glioma
Pediatric Brain Tumor, Optic Nerve Glioma

Interventions

DRUG: Carboplatin
DRUG: Vincristine
DRUG: Recombinant human endostatin

Sponsor

Beijing Sanbo Brain Hospital